Company
LON:POLX
Polarean Imaging PLC and its wholly owned subsidiary, Polarean Inc., are revenue-generating, medical imaging technology companies operating in the high-resolution medical imaging space. Polarean aspires to revolutionize pulmonary medicine by bringing the power and safety of MRI to the respiratory healthcare community in need of new solutions to evaluate lung function, diagnose disease, characterize disease progression, and monitor response to treatment.
177 stories · page 8 of 9
Hardware & electrical equipment
The grant was awarded from the National Heart, Lung and Blood Institute to Polarean and Cincinnati Children's Hospital Center. The money will continue to fund an ongoing Phase III trial evaluating the use of 129 Xe MRI scanning on children
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
MRI scans generally aren’t very useful in assessing lung function, but Polarean’s 129Xe gas is trying to change that
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A look at some of the biggest risers and fallers in London on Monday
Charles (Chuck) Osborne, Jr joins the company from oncology group Innocrin Pharmaceuticals and would start the role with immediately
It comes after latest data showed that core inflation in the US was flat last month (March) while consumer spending rose
Hardware & electrical equipment
The company invests and helps build companies in the medical and technology sectors, with a target exit valuation of over US$100mln
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's major movers, including Cluff Natural Resources, Coro Energy, Global Petroleum, Georgia Healthcare and GAN
CEO Richard Hullihen said: “UBC has a long history and pioneering reputation in the field of medical imaging research and I look forward to providing further updates regarding our collaboration with UBC as appropriate.”
Investments and investor services
Britain's blue chip index closed up around 39, or 0.55% at 7,236 on the day
Hardware & electrical equipment
“The company remains cash constrained and as previously announced continues to consider both its short term and medium-term funding options and work with the company's debt providers”
“The annual burden of pulmonary disease in the US is estimated to be over US$150bn and Polarean expects over US$500mln in system sales just to top-tier institutes,” read Northland’s note
